Breaking News
Get 55% Off 0
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.
See Undervalued Stocks
Close

Max Healthcare Institute Ltd (MAXE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,115.80 +18.75    +1.71%
15:10:45 - Delayed Data. Currency in INR
Type:  Equity
Market:  India
ISIN:  INE027H01010 
S/N:  MAXHEALTH
  • Volume: 48,836
  • Bid/Ask: 1,115.45 / 1,116.45
  • Day's Range: 1,060.00 - 1,121.25
Max Healthcare Institute 1,115.80 +18.75 +1.71%

NS:MAXE Financials

 
Gain a comprehensive overview of Max Healthcare Institute financials. Assess key figures from the balance sheet and income statement. Explore essential metrics such as total assets, total liabilities, equity, revenue, and net income to understand the company’s overall financial performance.

Max Healthcare Institute Limited reported earnings results for the second quarter and six months ended September 30, 2024. For the second quarter, the company reported sales was INR 17,074.6 million compared to INR 13,631.6 million a year ago. Revenue was INR 17,483 million compared to INR 14,086.4 million a year ago. Net income was INR 2,818.1 million compared to INR 2,766.8 million a year ago. Basic earnings per share from continuing operations was INR 2.9 compared to INR 2.85 a year ago. Diluted earnings per share from continuing operations was INR 2.88 compared to INR 2.84 a year ago. For the six months, sales was INR 32,504.1 million compared to INR 26,481.5 million a year ago. Revenue was INR 33,259.3 million compared to INR 27,349.5 million a year ago. Net income was INR 5,180.8 million compared to INR 5,167.6 million a year ago. Basic earnings per share from continuing operations was INR 5.33 compared to INR 5.32 a year ago. Diluted earnings per share from continuing operations was INR 5.3 compared to INR 5.3 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MAXE Income Statement

Gross margin TTM 62.3%
Operating margin TTM 22.32%
Net Profit margin TTM 17.63%
Return on Investment TTM 11.25%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 17074.6 15429.5 14229 13349.7
Gross Profit 10745.9 9462 8854.6 8370.2
Operating Income 3663.9 3105.1 3393.8 3249
Net Income 2818.1 2362.7 2515.4 2893.4

MAXE Balance Sheet

Quick Ratio MRQ 1.16
Current Ratio MRQ 1.26
LT Debt to Equity MRQ 12.1%
Total Debt to Equity MRQ 20.1%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 131268.7 119999.4
Total Liabilities 43278.1 35918
Total Equity 87990.6 84081.4 84081.4 78460.2

MAXE Cash Flow Statement

Cash Flow/Share TTM 13.5
Revenue/Share TTM 61.81
Operating Cash Flow  0.00%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MAXE Comments

Write your thoughts about Max Healthcare Institute Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bijal Naik
Bijal Naik Nov 16, 2022 21:09
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is going to perform well going forward looking at strong fundamentals and growth prospects.. The health care sector is going to gain momentum..
Debasish Baral
Debasish Baral Jul 06, 2022 18:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy position at 372
Arvind Patyal
Arvind Patyal Sep 20, 2021 17:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 480 next week must buy
Amit Sharma
Amit Sharma Sep 06, 2021 15:01
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next target 425 in this week
Ravi Kant
Ravi Kant Aug 26, 2021 7:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
target 390
Badusha alungal
Badusha alungal May 29, 2021 14:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Any views on result
Rajesh Modi
Rajesh Modi Dec 01, 2020 9:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Keep buying for 200
Syed Muzammil
Syed Muzammil Sep 23, 2020 9:34
Saved. See Saved Items.
This comment has already been saved in your Saved Items
126 se sidha niche 110....
Ajay Sharma
Ajay Sharma Sep 13, 2020 18:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Awesome.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email